Site is loading…
Lancaster General Hospital Ann B Barshinger Cancer Institute is a clinical research site located in Lancaster, Pennsylvania, United States 17601.
Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.
Lancaster General Hospital Ann B Barshinger Cancer Institute has participated in 11 clinical trials with 9 currently active.
Therapeutic areas: Non Small Cell Lung Cancer, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms.
Sponsors: Merck Sharp & Dohme LLC, Eli Lilly and Company, Bristol-Myers Squibb.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Lancaster
Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lancaster General Hospital Ann B Barshinger Cancer Institute has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lancaster General Hospital Ann B Barshinger Cancer Institute has 11 clinical trials on record, with 9 currently active. Their work covers Non Small Cell Lung Cancer, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms.
Lancaster General Hospital Ann B Barshinger Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.